About HUB:

Hubrecht Organoid Technology (HUB) is a fast-growing biotech company, founded on the pioneering work of Prof. Dr. Hans Clevers who discovered methods to grow stem cell-derived human epithelial “mini-organs” (organoids) from tissues of patients with various diseases including cancer and cystic fibrosis. HUB builds comprehensive Living Biobanks of well-characterized organoids and develops assays for drug screening and validation. The Organoid Technology enables predictive diagnostics and clinical trial patient stratification.

We are currently seeking a highly motivated Scientist for one of our Research Groups.


Scope of position:

A Scientist at HUB supports Research Projects, commissioned by pharmaceutical companies. This position allows you to drive state of the art research with the aim to develop innovative applications for Organoid Technology.

As a scientist at HUB, you will be working with the top researchers in the field of adult (cancer) stem cells and 3D culture. You will interact with external parties and present novel findings at international scientific meetings.

The successful candidate will learn from and contribute to the world leader biotech company on Organoid Technology that has already disrupted human health, providing patients access to novel treatments.



Suitable candidates will have a PhD in oncology, immuno-oncology, or a related field, followed by at least one-year of postdoc experience.

Research background in one or more of the following areas is preferred:

  • Working experience in oncology and/or immunology.
  • Laboratory-based experience in cell biology, cell culture and assay development.
  • A working knowledge of gene-editing technologies, including CRISPR.
  • Candidates must display an ability to independently design and execute research. In addition to a   broad knowledge of oncology and/or immunology, we are seeking an individual with deep intellectual curiosity, and excellent communication and interpersonal skills.


What we offer:

A high paced, professional and international environment.

A positive and energetic team allowing you to really make a difference.

Opportunity to grow in this position alongside HUB’s development.



 We look forward to receiving your cover letter together with your resume, in English.

Please send it to Arianne Piesaar-Aalbers, HR Manager (

October 18, 2019 CrownBio launched patient-derived tumor organ... San Diego, October 17, 2019 – Crown Bioscience today announced the launch of a new tumor organoid drug development pl... read more
October 01, 2019 Hubrecht Organoid Technology and MIMETAS to d... Leiden, Utrecht September 2019 MIMETAS and Hubrecht Organoid Technology (HUB) announce that they entered into a strategi... read more
July 17, 2019 Epistem license Hubrecht Organoid Technology ... Epistem license Hubrecht Organoid Technology to expand preclinical toxicology service portfolio Manchester, 16th July, 2... read more